Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference


Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on April 9, 2024, at 11 a.m. ET.

A live webcast of the fireside chat will be accessible from the Investor section of the company's website at www.bicycletherapeutics.com. A replay of the webcast will be archived and available following the event.

About Bicycle Therapeutics

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating BT8009, a Bicycle® Toxin Conjugate (BTC®) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC targeting EphA2, a historically undruggable target; and BT7480, a Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) targeting Nectin-4 and agonizing CD137, in company-sponsored clinical trials. Additionally, the company is developing Bicycle® Radio Conjugates (BRCtm) for radiopharmaceutical use and, through various partnerships, is exploring the use of Bicycle® technology to develop therapies for diseases beyond oncology.

Bicycle Therapeutics is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Cambridge, Mass. For more information, visit bicycletherapeutics.com.


These press releases may also interest you

at 17:45
The global automotive battery testers market  size is estimated to grow by USD 78.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.73%  during the forecast period.  Increasing lifespan of...

at 17:44
Non-cash impairment of SEK 11.4 billion to be recorded in the second quarter 2024, relating to the impairment of intangibles mainly attributed to the Vonage acquisitionReflects lower anticipated market growth in some of Vonage's current portfolioThe...

at 17:40
Bayen Group, a leading provider of IT solutions and services, has been nominated for the prestigious Southern California Minority Supplier Development Council (SCMSDC) Supplier of the Year award by Northrop Grumman, a global aerospace and defense...

at 17:25
The global secondary tickets market size is estimated to grow by USD 132.1 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 34.25% during the forecast period. Rising popularity of sports events is driving...

at 17:25
The global electric car rental market size is estimated to grow by USD 18.00 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.68% during the forecast period. Increasing demand for rental cars due...

at 17:20
The global supercomputer market size is estimated to grow by USD 33.45 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 28.54% during the forecast period. Commercial customers increasingly adopting...



News published on and distributed by: